AT

Anshul Thakral

Opthea Limited | Non-Executive Director
Mr Thakral is Chief Executive Officer and Board Member of Launch Therapeutics, a clinical development company backed by funds managed by global investment firm Carlyle and its life sciences franchise, Abingworth. Mr Thakral has worked for over 20 years in the pharmaceutical and biotechnology industry and is an experienced executive, management consultant and entrepreneur. Mr Thakral was previously Chief Commercial Officer and Executive Vice President of Peri and Post-Approval Services at PPD, and prior to that was Global Head of PPD Biotech. Before PPD, Mr Thakral ran the global life sciences business unit at Gerson Lehrman Group and worked at McKinsey & Company as an associate principal in the health care practice, where he provided strategic advice to global pharmaceutical and biotechnology companies on growth, research and development, business development and commercialization. He currently serves on the boards of TriNetX, Saama Technologies, Orsini Specialty Pharmacy, is an Operating Executive at Carlyle and is a Venture Partner at Abingworth.

Company and Role

Company
Title
Tenure
Since
OPT
Opthea Limited
  • Non-Executive Director
1yrs, 1mthJun 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
OPT
Opthea Limited
21/12/230N/A1,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
OPT
Opthea Limited
21/12/23
Issued
1,000,000$0.470$470,000Issue of options